-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Reiterates Overweight on Alkermes, Raises Price Target to $65

Benzinga·07/28/2026 15:59:16
Listen to the news
Piper Sandler analyst David Amsellem reiterates Alkermes (NASDAQ:ALKS) with a Overweight and raises the price target from $43 to $65.